Selective cholinesterase inhibitors from Buxus sempervirens L. and their molecular docking studies

Current Computer-Aided Drug Design

Volumn 7, Issue 4, 2011, Pages 276-286

  Orhan, Ilkay E ^a,d   Khan, Mahmud T H ^b   Erdem, Sinem A ^c   Kartal, Murat ^c   Şener, Bilge ^a  

^a GAZI UNIVERSITY   (Turkey)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c ANKARA UNIVERSITY   (Turkey)

^d EASTERN MEDITERRANEAN UNIVERSITY   (Turkey)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Docking; Homology modeling

Indexed keywords

BIOASSAY; HYDROPHOBICITY; NEURODEGENERATIVE DISEASES; QUANTUM THEORY;

ACETYLCHOLINESTERASE; ALZHEIMERS DISEASE; BIOASSAY-GUIDED FRACTIONATION; BUTYRYLCHOLINESTERASE; DOCKING; DOCKING STUDIES; HOMOLOGY MODELING; INHIBITORY ACTIVITY; MOLECULAR DOCKING; SELECTIVE INHIBITORS;

DENSITY FUNCTIONAL THEORY;

ACETYLCHOLINESTERASE; BUXABENZAMIDIENINE; BUXAMIDINE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; BUXUS; BUXUS SEMPERVIRENS; CHOLINESTERASE INHIBITION; DRUG ACTIVITY; DRUG ISOLATION; EEL; HUMAN; IC 50; IN VITRO STUDY; MOLECULAR DOCKING; NONHUMAN; PLANT ROOT;

EID: 82955190133     PISSN: 15734099     EISSN: 18756697     Source Type: Journal    
DOI: 10.2174/157340911798260296     Document Type: Article

References (29)

1. Taylor, P.; Radic, Z. The cholinesterases: from genes to proteins. Ann. Rev. Pharmacol. Toxicol., 1994, 34, 281-320.
2. Nachon, F.; Nicolet, Y.; Masson, P. Butyrylcholinesterase: 3D structure, catalytic mechanisms. Ann. Pharm. Fr., 2005, 63, 194 206.
3. Terry, A.V. Jr; Buccafusco, J.J. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther., 2003, 306, 821-827.
4. Lahiri, D.K.; Farlow, M.R.; Hintz, N.; Utsuki, T.; Greig, N.H. Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease. Acta Neurol. Scand. Suppl., 2000, 176, 60-67.
5. Musial, A.; Bajda, M.; Malawska, B. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Curr. Med. Chem., 2007, 14, 2654-2679.
6. Zhang, H.Y.; Yan, H.; Tang, X.C. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase. Cell. Mol. Neurobiol., 2007, 28, 173-183.
7. Kvaltinova, Z.; Lukovic, L.; Machova, J.; Fatranska, M. Effect of the steroidal E-alkaloid buxaminol on blood pressure, acetylcholinesterase activity and (3H) quinuclidinyl benzilate binding in cerebral cortex. Pharmacology, 1991, 43, 20-25.
8. Kalauni, S.K.; Choudhary, M.I.; Khalid, A.; Manandhar, M.D.; Shaheen, F.; Atta-ur-Rahman; Gewali, M.B. New cholinesterase inhibiting steroidal alkaloids from the leaves of Sarcococca coriacea of Nepalese origin. Chem. Pharm. Bull., 2002, 50, 1423 1426.
9. Khalid, A.; Zaheer-ul-Huq; Ghayur, M.N.; Feroz, F.; Atta-ur Rahman; Gilani, A.H.; Choudhary, M.I. Cholinesterase inhibitory and spasmolytic potential of steroidal alkaloids. J. Steroid Biochem. Mol. Biol., 2004, 92, 477-484.
10. Khalid, A.; Azim, M.K.; Parveen, S.; Atta-ur-Rahman; Choudhary, M.I. Structural basis of acetylcholinesterase inhibition by triterpenoidal alkaloids. Biochem. Biophys. Res. Commun., 2005, 331, 1528-1532.
11. Woodruff-Pak, D.S.; Tobia, M.J.; Jiao, X.; Beck, K.D.; Servatius, R.J. Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil. Neuropsychopharmacology, 2007, 32, 1284-1294.
12. Villarroya, M.; Garcia, A.G.; Marco-Contelles, J.; Lopez, M.G. An update on the pharmacology of galantamine. Expert Opin. Invest. Drugs, 2007, 16, 1987-1998.
13. Orhan, I.; Şener, B.; Choudhary, M.I.; Khalid, A. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. J. Ethnopharmacol., 2004, 91, 57-60.
14. Ellman, G.L.; Courtney, K.D.; Andres, V.; Feather-Stone, R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol., 1961, 7, 88-95.
15. Orhan, I.; Kartal, M.; Naz, Q.; Yilmaz, G.; Kan, Y.; Konuklugil, B.; Şener, B.; Choudhary, M.I. Antioxidant and anticholinesterase evaluation of selected Turkish Salvia species. Food Chem., 2007, 103, 1247-1254.
16. Altschul, S.F.; Gish, W.; Miller, W.; Myers, E.W.; Lipman, D.J. Basic local alignment search tool. J. Mol. Biol., 1990, 215, 403 410.
17. Altschul, S.F.; Madden, T.L.; Schaffer, A.A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Res., 1997, 25, 3389-3402.
18. Ngamelue, M.N.; Homma, K.; Lockridge, O.; Asojo, O.A. Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase. Acta Crystallogr. Sect. F Struct. Biol. Crystallogr. Commun., 2007, 63, 723-727.
19. Guex, N.; Peitsch, M.C. SWISS-MODEL and the Swiss PdbViewer: an environment for comparative protein modeling. Electrophoresis, 1997, 18, 2714-2723.
20. Schwede, T.; Kopp, J.; Guex, N.; Peitsch, M.C. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acid Res., 2003, 31, 3381-3385.
21. Arnold, K.; Bordoli, L.; Kopp, J.; Schwede, T. The SWISSMODEL Workspace: A web-based environment for protein structure homology modelling. Bioinformatics, 2006, 22, 195-201.
22. Abagyan, R.A.; Totrov, M.M.; Kuznetsov, D.A. Icm: a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J. Comp. Chem., 1994, 15, 488-506.
23. Bourne, Y.; Grassi, J.; Bougis, P.E.; Marchot, P. Conformational flexibility of the acetylcholinesterase tetramer suggested by x-ray crystallography. J. Biol. Chem., 1999, 274, 30370-30376.
24. Kryger, G.; Harel, M.; Giles, K.; Toker, L.; Velan, B.; Lazar, A.; Kronman, C.; Barak, D.; Ariel, N.; Shafferman, A.; Silman, I.; Sussman, J.L. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr. D Biol. Crystallogr., 2000, 56, 1385-1394.
25. Holm, L.; Park, J. DaliLite workbench for protein structure comparison. Bioinformatics, 2000, 16, 566-567.
26. Schapira, M.; Totrov, M.; Abagyan, R. Prediction of the binding energy for small molecules, peptides and proteins. J. Mol. Recog., 1999, 12, 177-190.
27. Wallace, A.C.; Laskowski, R.A.; Thornton, J.M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng., 1995, 8, 127-134.
28. Wiesner, J.; Kriz, Z.; Kuca, K.; Jun, D.; Koca, J. Acetylcholinesterases--the structural similarities and differences. J. Enzyme Inhib. Med. Chem., 2007, 22, 417-424.
29. Bourne, Y.; Taylor, P.; Radic, Z.; Marchot, P. Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. EMBO J., 2003, 22, 1-12.